Farallon enters Kalbe Farma
US-based investment company Farallon is buying shares of PT Kable Farma Tbk, a pharmaceutical company with Rp13.4 trillion market capitalization. It's not clear how much shares being acquired. "It's a passive investment," one banker said.
As of last month, 52.87% shares of Kalbe is controlled by six controlling companies. They're PT Bina Artha Charisma (8.59%), PT Gira Sole Prima (9.41%), PT Ladang Ira Panen (8.58%), PT Lucasta Murni Cemerlang (8.74%), PT Diptanala Bahana (8.64%), and PT Santa Seha Sanadi (8.92%).
READ MORE!!!
As of last month, 52.87% shares of Kalbe is controlled by six controlling companies. They're PT Bina Artha Charisma (8.59%), PT Gira Sole Prima (9.41%), PT Ladang Ira Panen (8.58%), PT Lucasta Murni Cemerlang (8.74%), PT Diptanala Bahana (8.64%), and PT Santa Seha Sanadi (8.92%).
READ MORE!!!
posted by yosef at 10:00 AM
4 Comments:
If Ray Zagge has put money into this company it must be worth investing in!
Ownership structure makes it an obivous takeover target. Looks a smart investment if true
Who is Ray Zagge?
Brief info on Raymond Zage
Mr. Zage joined Farallon® in 2000. Mr. Zage is now the managing director of Noonday Asset Management Asia Pte. Ltd.
Previous to joining Farallon®, Mr. Zage was a vice president in the investment banking division of Goldman Sachs in Singapore, where he was responsible for working on mergers & acquisitions and corporate finance assignments for companies throughout Asia. Prior to moving to Singapore, Mr. Zage worked in the financial institutions group at Goldman Sachs in both New York and Los Angeles, where he focused on bank mergers and acquisitions. He also worked as a certified public accountant for PriceWaterhouse in New York.
Mr. Zage graduated with a B.S. degree in Accounting and Finance from the University of Illinois at Urbana Champaign.
Post a Comment
<< Home